VRTX•benzinga•
Canaccord Genuity Maintains Sell on Vertex Pharmaceuticals, Raises Price Target to $408
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 6, 2024 by benzinga